Ajinomoto Bio-Pharma’s oligonucleotide offering provides research products and contract services for organizations working in nucleic acid research and development. Its portfolio includes DNA and RNA oligonucleotides, sgRNA, siRNA, BNA and LNA oligonucleotides, and miRNA mimics and inhibitors. The company also offers siRNA sequence design, peptide products, research-use oligonucleotides, and consumables and reagents for nucleic acid synthesis.

For customers seeking development and production support, Ajinomoto Bio-Pharma lists CDMO services alongside contract analytical services. Its site also highlights platform technologies, long RNA synthesis, product catalogs, and pricing information for products and contracted services. News, press releases, events, and product campaigns provide updates on the organization’s activities and offerings.

The brand presents its oligonucleotide capabilities as part of a broader research and service platform, serving users who need specialized nucleic acid materials, design support, analysis, or contract development and manufacturing. Its website is available in Japanese and English and provides company, access, and contact information.